This on-demand webinar discusses a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment. 

Erle Robertson, a professor of Microbiology at the University of Pennsylvania's Perelman School of Medicine, discusses the PathoChip, a 60,000-probe comparative genomic hybridization microarray that was developed to target viral, prokaryotic, and eukaryotic genomes.